Cadila, India's sixth-largest drugmaker by sales, spent $250 million developing Lipaglyn, a new chemical entity or new discovery, and aims to spend another $150 million to $200 million to launch the drug outside India.

Financial risk is always associated with drug discovery. But the benefit that a blockbuster drug can bring to the business can be phenomenal if you can take that risk.

Thinking of possibilities is like driving a car on a freeway. You have an open road that stretches endlessly before you where your thoughts are not shackled. But when we say 'impossible,' we have already reached a dead-end in our minds. So dwell on possibilities to open up your horizon.

One of the big myths about philanthropy is that it's all about donating funds for a cause. I like to look at it quite differently. Philanthropy is about 'giving' - not just in monetary terms but also in non-monetary aspects, like time, ideas, or being a volunteer. Donating money is just a small part of philanthropy.

During an economic slowdown, one needs to be cautious, but I think it's equally important to not get sucked into the vortex of defensive thinking.

What we do tomorrow is more important than what we did yesterday.